Literature DB >> 25664129

Clinical and molecular effect on offspring of a marriage of consanguineous spinocerebellar ataxia type 7 mutation carriers: a family case report.

Jonathan J Magaña1, Yessica S Tapia-Guerrero1, Luis Velázquez-Pérez2, Tania Cruz-Mariño3, Cesar M Cerecedo-Zapata4, Rocío Gómez5, Nadia M Murillo-Melo1, Rigoberto González-Piña6, Oscar Hernández-Hernández1, Bulmaro Cisneros7.   

Abstract

Spinocerebellar ataxia type 7 (SCA7) is a genetic disorder characterized by degeneration of the cerebellum, brainstem, and retina that is caused by abnormal expansion of a CAG repeat located in the ATXN7 gene encoding sequence on chromosome 3p21.1. Although SCA7 is an uncommon autosomal dominant ataxia, we previously found increased prevalence of the disease in a Southeastern Mexican population. In this study, we described to our knowledge for the first time a marriage of consanguineous SCA7 mutation carriers and their offspring effect. We characterized a severely affected infantile-onset female patient whose parents and two siblings exhibited no symptoms of the disease at time of diagnosis. A comprehensive clinical analysis of the proband showed a progressive cerebellar syndrome, including gait ataxia, movement disorders, and saccadic movements, as well as hyperreflexia, visual deterioration, urinary and cardiovascular dysfunction, and impaired nerve conduction. The SCA7 mutation was detected in the proband patient. Subsequently, genetic examination using four ATXN7 gene-linked markers (three centromeric microsatellite markers [D3S1228, D3S1287, and D3S3635] and an intragenic Single Nucleotide Polymorphism [SNP-3145G/A]) revealed that the proband descends from a couple of consanguineous SCA7 mutation carriers. Genotyping analysis demonstrated that all offspring inherited only one mutant allele, and that the severe infantile-onset phenotype is caused by germinal expansion (from 37 to 72 CAG repeats) of the paternal mutant allele. Interestingly, the couple also referred a miscarriage. Finally, we found no CAA interruptions in the ATXN7 gene CAG repeats tract in this family, which might explain, at least in part, the triplet instability in the proband.

Entities:  

Keywords:  CAA interruptions; CAG repeats; consanguineous marriage; electrophysiological findings; infantile-onset phenotype; intergenerational transmission; spinocerebellar ataxia type 7

Year:  2014        PMID: 25664129      PMCID: PMC4307576     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  26 in total

1.  Very large (CAG)(n) DNA repeat expansions in the sperm of two spinocerebellar ataxia type 7 males.

Authors:  D G Monckton; M L Cayuela; F K Gould; G J Brock; R Silva; T Ashizawa
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

2.  Large pathogenic expansions in the SCA2 and SCA7 genes can be detected by fluorescent repeat-primed polymerase chain reaction assay.

Authors:  Claudia Cagnoli; Giovanni Stevanin; Chiara Michielotto; Giovanni Gerbino Promis; Alessandro Brussino; Patrizia Pappi; Alexandra Durr; Elisa Dragone; Michelle Viemont; Cinzia Gellera; Alexis Brice; Nicola Migone; Alfredo Brusco
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

3.  Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families.

Authors:  M L Moseley; K A Benzow; L J Schut; T D Bird; C M Gomez; P E Barkhaus; K A Blindauer; M Labuda; M Pandolfo; M D Koob; L P Ranum
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

4.  Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family.

Authors:  J Martin; N Van Regemorter; J Del-Favero; A Löfgren; C Van Broeckhoven
Journal:  J Neurol Sci       Date:  1999-09-15       Impact factor: 3.181

5.  Outcome and effect of pregnancy in myotonic dystrophy type 2.

Authors:  S Rudnik-Schöneborn; C Schneider-Gold; U Raabe; W Kress; K Zerres; B G H Schoser
Journal:  Neurology       Date:  2006-02-28       Impact factor: 9.910

Review 6.  Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.

Authors:  J J Magaña; L Velázquez-Pérez; B Cisneros
Journal:  Mol Neurobiol       Date:  2012-09-21       Impact factor: 5.590

7.  Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion.

Authors:  G David; N Abbas; G Stevanin; A Dürr; G Yvert; G Cancel; C Weber; G Imbert; F Saudou; E Antoniou; H Drabkin; R Gemmill; P Giunti; A Benomar; N Wood; M Ruberg; Y Agid; J L Mandel; A Brice
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

8.  Spinocerebellar ataxia type 7: clinical course, phenotype-genotype correlations, and neuropathology.

Authors:  Laura C Horton; Matthew P Frosch; Mark G Vangel; Carol Weigel-DiFranco; Eliot L Berson; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

9.  Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2.

Authors:  Luis Velázquez Pérez; Gilberto Sánchez Cruz; Nalia Canales Ochoa; Roberto Rodríguez Labrada; Julio Rodríguez Díaz; Luis Almaguer Mederos; José Laffita Mesa
Journal:  J Neurol Sci       Date:  2007-08-13       Impact factor: 3.181

10.  Childhood-onset ataxia: testing for large CAG-repeats in SCA2 and SCA7.

Authors:  Rong Mao; Arthur S Aylsworth; Nicholas Potter; William G Wilson; Galen Breningstall; Myra J Wick; Dusica Babovic-Vuksanovic; Martha Nance; Marc C Patterson; Christopher M Gomez; Karen Snow
Journal:  Am J Med Genet       Date:  2002-07-15
View more
  1 in total

Review 1.  Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean.

Authors:  Roberto Rodríguez-Labrada; Ana Carolina Martins; Jonathan J Magaña; Yaimeé Vazquez-Mojena; Jacqueline Medrano-Montero; Juan Fernandez-Ruíz; Bulmaro Cisneros; Helio Teive; Karen N McFarland; Maria Luiza Saraiva-Pereira; César M Cerecedo-Zapata; Christopher M Gomez; Tetsuo Ashizawa; Luis Velázquez-Pérez; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2020-06       Impact factor: 3.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.